# Senomyx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/senomyx

- Industry: Logistics & Distribution
- Headquarters: San Diego, US
- Website: www.senomyx.com
- Total disclosed funding: $47M
- Latest round: Series E (Mar 11, 2002)
- Investors on record: 11

## About

Senomyx, Inc. specializes in flavor innovation, using proprietary technology to develop taste enhancing ingredients for food and beverage applications, contributing to healthier product formulations.Founded in 1998 and headquartered in San Diego, US, Senomyx, Inc. develops flavor-enhancing ingredients for the food and beverage industry. The company went public on June 22, 2004, raising USD 36.00 mn in its IPO, which is the total amount raised. The investments focused on enhancing its proprietary flavor technology. No details on mergers or subsidiaries are available.Senomyx, Inc. offers a range of flavor enhancement products designed to meet the diverse needs of food and beverage manufacturers. Their primary offerings focus on creating safe, effective flavor ingredients that improve taste while reducing the need for sugars and salts. Their solutions aim to assist clients in reformulating products to meet health trends and consumer preferences, thereby broadening their market appeal across various regions, including North America and Europe.In the most recent year, 2017, Senomyx, Inc. reported a revenue of USD 29.32 mn with an EBITDA of USD -795,000. The company's revenue generation primarily comes from partnerships with food and beverage companies, providing innovative flavor solutions that contribute to their clients' product development initiatives.Senomyx, Inc. is focused on expanding its product line with new flavor enhancers to be launched in the upcoming years, targeting specific health-conscious markets. The company plans to penetrate Asian markets by 2025, utilizing the recent funding from its IPO to support research and development. This strategic expansion aims to enhance its global footprint and cater to evolving consumer demands for healthier food options.

## Funding rounds

- Series E, Mar 11, 2002, $37M — Domain Associates, OrbiMed Advisors, Prospect Venture Partners, RHO, Bay City Capital, Tekla Capital Management, Bank of America Global Capital Management, Merrill Lynch Ventures, United States Trust Company of New York
- Series B, Sep 14, 2000, $10M — Domain Associates, Prospect Venture Partners, RHO, Bay City Capital, Baker-Tisch Investments, Kingsbury Capital Partners

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series E
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series B, Series E
- RHO (https://capitalatlas.ai/funds/rho) — Series B, Series E
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series B, Series E
- Baker-Tisch Investments — Series B
- Kingsbury Capital Partners — Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series E
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series E
- Bank of America Global Capital Management (https://capitalatlas.ai/funds/bank-of-america-global-capital-management) — Series E
- Merrill Lynch Ventures — Series E
- United States Trust Company of New York — Series E